Sulfacetamide Sodium NDC 76420-076

NDC codes

FDA NDC Directory

Product NDC (as listed)76420-076Labeler and product segments. Claims need a package NDC.

Product NDC at billing width76420-0076Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
76420-076-15	76420007615	15 mL in 1 BOTTLE, PLASTIC (76420-076-15)Marketed from Jan 16, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sulfacetamide Sodium
Generic name (nonproprietary): sulfacetamide sodium
Active ingredients: Sulfacetamide sodium — 100 mg/mL
Dosage form: Solution
Route: Ophthalmic
Labeler: Asclemed USA, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 089560
Marketing start: Mar 25, 2003
Listing expires: Dec 31, 2026
Other FDA classes: Sulfonamides (Chemical structure)
Identifiers: Product ID 76420-076_ead2d6e4-62f6-3b3c-e053-2a95a90a4ccdSPL ID ead2d6e4-62f6-3b3c-e053-2a95a90a4ccdSPL set ID c4c29e13-8303-4a9a-bb47-d7413eaf2f26RxCUI 1006120UNII 4NRT660KJQ
Pharmacologic class: Sulfonamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N476420007615 followed by a unit qualifier and the quantity

Package 76420-0076-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 12, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE: Sulfacetamide Sodium Ophthalmic Solution USP, 10% is indicated for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus (viridans group), Haemophilus influenzae, Klebsiella species, and Enterobacter species. Topically applied sulfonamides do not provide adequate coverage against Neisseria species, Serratia marcescens and Pseudomonas aeruginosa . A significant percentage of staphylococcal isolates are completely resistant to sulfa drugs.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)